Related Experiment Videos
Anxiety reduction after chorionic villus sampling and genetic amniocentesis
G E Robinson1, D M Garner, M P Olmsted
1Department of Psychiatry, Faculty of Medicine, Toronto General Hospital, University of Toronto, Ontario, Canada.
American Journal of Obstetrics and Gynecology
|October 1, 1988
Summary
Women undergoing chorionic villus sampling (CVS) experienced reduced anxiety sooner than those receiving genetic amniocentesis. CVS offers earlier prenatal testing and quicker anxiety relief for expectant mothers.
Area of Science:
- Medical research
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Prenatal diagnosis is crucial for managing pregnancy complications.
- Chorionic villus sampling (CVS) and genetic amniocentesis are common prenatal diagnostic procedures.
- CVS offers earlier results but carries a higher miscarriage risk than amniocentesis.
Purpose of the Study:
- To compare anxiety levels in pregnant women undergoing CVS versus genetic amniocentesis.
- To evaluate the psychological impact of the timing of results for each procedure.
- To determine which prenatal testing method provides earlier anxiety reduction.
Main Methods:
- A randomized trial comparing CVS and genetic amniocentesis.
- Anxiety levels were assessed in women at four specific gestational time points.
- Participants were grouped based on the prenatal testing method they received.
Main Results:
- The CVS group showed a significant decrease in anxiety after receiving their test results.
- The genetic amniocentesis group experienced sustained anxiety until all results were known.
- Earlier testing with CVS led to more rapid and lasting anxiety reduction.
Conclusions:
- Chorionic villus sampling provides earlier and more sustained anxiety reduction compared to genetic amniocentesis.
- The timing of prenatal diagnostic results significantly impacts maternal anxiety levels.
- CVS may be a preferred method for women seeking timely results and psychological relief.